nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—UGT2B7—Epirubicin—ovarian cancer	0.373	0.518	CbGbCtD
Flunitrazepam—CYP3A4—Topotecan—ovarian cancer	0.0764	0.106	CbGbCtD
Flunitrazepam—CYP2B6—Doxorubicin—ovarian cancer	0.0663	0.0921	CbGbCtD
Flunitrazepam—CYP2C9—Paclitaxel—ovarian cancer	0.065	0.0902	CbGbCtD
Flunitrazepam—CYP3A4—Vinorelbine—ovarian cancer	0.0538	0.0747	CbGbCtD
Flunitrazepam—CYP3A4—Paclitaxel—ovarian cancer	0.0378	0.0525	CbGbCtD
Flunitrazepam—CYP3A4—Docetaxel—ovarian cancer	0.0273	0.0379	CbGbCtD
Flunitrazepam—CYP3A4—Doxorubicin—ovarian cancer	0.0204	0.0283	CbGbCtD
Flunitrazepam—Ataxia—Altretamine—ovarian cancer	0.0085	0.0649	CcSEcCtD
Flunitrazepam—TSPO—oviduct—ovarian cancer	0.00628	0.155	CbGeAlD
Flunitrazepam—Fatigue—Altretamine—ovarian cancer	0.00383	0.0292	CcSEcCtD
Flunitrazepam—Asthenia—Altretamine—ovarian cancer	0.00319	0.0243	CcSEcCtD
Flunitrazepam—Ataxia—Chlorambucil—ovarian cancer	0.00302	0.0231	CcSEcCtD
Flunitrazepam—Dizziness—Altretamine—ovarian cancer	0.00294	0.0224	CcSEcCtD
Flunitrazepam—Hallucination—Chlorambucil—ovarian cancer	0.00221	0.0169	CcSEcCtD
Flunitrazepam—Muscular weakness—Vinorelbine—ovarian cancer	0.00216	0.0165	CcSEcCtD
Flunitrazepam—Sweating—Topotecan—ovarian cancer	0.00211	0.0161	CcSEcCtD
Flunitrazepam—TSPO—myometrium—ovarian cancer	0.00201	0.0495	CbGeAlD
Flunitrazepam—UGT2B7—female reproductive system—ovarian cancer	0.002	0.0492	CbGeAlD
Flunitrazepam—TSPO—embryo—ovarian cancer	0.00193	0.0476	CbGeAlD
Flunitrazepam—Tremor—Chlorambucil—ovarian cancer	0.00181	0.0138	CcSEcCtD
Flunitrazepam—Agitation—Chlorambucil—ovarian cancer	0.00178	0.0136	CcSEcCtD
Flunitrazepam—Angioedema—Chlorambucil—ovarian cancer	0.00177	0.0135	CcSEcCtD
Flunitrazepam—UGT2B7—testis—ovarian cancer	0.00161	0.0397	CbGeAlD
Flunitrazepam—Ill-defined disorder—Topotecan—ovarian cancer	0.0016	0.0122	CcSEcCtD
Flunitrazepam—Confusional state—Chlorambucil—ovarian cancer	0.00159	0.0122	CcSEcCtD
Flunitrazepam—TSPO—epithelium—ovarian cancer	0.00158	0.0388	CbGeAlD
Flunitrazepam—Angioedema—Topotecan—ovarian cancer	0.00157	0.012	CcSEcCtD
Flunitrazepam—TSPO—uterine cervix—ovarian cancer	0.00156	0.0385	CbGeAlD
Flunitrazepam—Malaise—Topotecan—ovarian cancer	0.00155	0.0119	CcSEcCtD
Flunitrazepam—Ataxia—Paclitaxel—ovarian cancer	0.00155	0.0118	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.0015	0.0115	CcSEcCtD
Flunitrazepam—TSPO—decidua—ovarian cancer	0.00149	0.0367	CbGeAlD
Flunitrazepam—GABRA5—testis—ovarian cancer	0.00147	0.0363	CbGeAlD
Flunitrazepam—Muscular weakness—Paclitaxel—ovarian cancer	0.00145	0.0111	CcSEcCtD
Flunitrazepam—Discomfort—Topotecan—ovarian cancer	0.00145	0.0111	CcSEcCtD
Flunitrazepam—TSPO—endometrium—ovarian cancer	0.00141	0.0348	CbGeAlD
Flunitrazepam—Dysarthria—Epirubicin—ovarian cancer	0.00137	0.0105	CcSEcCtD
Flunitrazepam—GABRA3—testis—ovarian cancer	0.00137	0.0337	CbGeAlD
Flunitrazepam—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00137	0.0104	CcSEcCtD
Flunitrazepam—Fatigue—Chlorambucil—ovarian cancer	0.00136	0.0104	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Topotecan—ovarian cancer	0.00136	0.0104	CcSEcCtD
Flunitrazepam—Angioedema—Vinorelbine—ovarian cancer	0.00135	0.0103	CcSEcCtD
Flunitrazepam—Tachycardia—Melphalan—ovarian cancer	0.00134	0.0103	CcSEcCtD
Flunitrazepam—Malaise—Vinorelbine—ovarian cancer	0.00133	0.0101	CcSEcCtD
Flunitrazepam—Ataxia—Docetaxel—ovarian cancer	0.00131	0.01	CcSEcCtD
Flunitrazepam—TSPO—gonad—ovarian cancer	0.00131	0.0323	CbGeAlD
Flunitrazepam—TSPO—uterus—ovarian cancer	0.0013	0.0321	CbGeAlD
Flunitrazepam—Feeling abnormal—Chlorambucil—ovarian cancer	0.0013	0.00993	CcSEcCtD
Flunitrazepam—Hiccups—Epirubicin—ovarian cancer	0.0013	0.00989	CcSEcCtD
Flunitrazepam—CYP2A6—vagina—ovarian cancer	0.00129	0.0319	CbGeAlD
Flunitrazepam—Hypotension—Melphalan—ovarian cancer	0.00129	0.00982	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Docetaxel—ovarian cancer	0.00127	0.00972	CcSEcCtD
Flunitrazepam—Dysarthria—Doxorubicin—ovarian cancer	0.00127	0.00968	CcSEcCtD
Flunitrazepam—Discomfort—Vinorelbine—ovarian cancer	0.00124	0.00946	CcSEcCtD
Flunitrazepam—Fatigue—Topotecan—ovarian cancer	0.00121	0.00925	CcSEcCtD
Flunitrazepam—Hiccups—Doxorubicin—ovarian cancer	0.0012	0.00915	CcSEcCtD
Flunitrazepam—Fatigue—Melphalan—ovarian cancer	0.00119	0.00906	CcSEcCtD
Flunitrazepam—Tachycardia—Vinorelbine—ovarian cancer	0.00117	0.00896	CcSEcCtD
Flunitrazepam—TSPO—female reproductive system—ovarian cancer	0.00117	0.0288	CbGeAlD
Flunitrazepam—Feeling abnormal—Topotecan—ovarian cancer	0.00116	0.00884	CcSEcCtD
Flunitrazepam—GABRA2—vagina—ovarian cancer	0.00114	0.0282	CbGeAlD
Flunitrazepam—Asthenia—Chlorambucil—ovarian cancer	0.00113	0.00865	CcSEcCtD
Flunitrazepam—Hypotension—Vinorelbine—ovarian cancer	0.00112	0.00858	CcSEcCtD
Flunitrazepam—TSPO—bone marrow—ovarian cancer	0.00111	0.0272	CbGeAlD
Flunitrazepam—TSPO—female gonad—ovarian cancer	0.00107	0.0262	CbGeAlD
Flunitrazepam—TSPO—vagina—ovarian cancer	0.00106	0.0261	CbGeAlD
Flunitrazepam—Fatigue—Vinorelbine—ovarian cancer	0.00104	0.00791	CcSEcCtD
Flunitrazepam—Asthenia—Topotecan—ovarian cancer	0.00101	0.0077	CcSEcCtD
Flunitrazepam—Feeling abnormal—Vinorelbine—ovarian cancer	0.000991	0.00756	CcSEcCtD
Flunitrazepam—Asthenia—Melphalan—ovarian cancer	0.000988	0.00754	CcSEcCtD
Flunitrazepam—TSPO—testis—ovarian cancer	0.000945	0.0233	CbGeAlD
Flunitrazepam—Diplopia—Epirubicin—ovarian cancer	0.000941	0.00718	CcSEcCtD
Flunitrazepam—Dizziness—Topotecan—ovarian cancer	0.00093	0.00709	CcSEcCtD
Flunitrazepam—Tremor—Paclitaxel—ovarian cancer	0.000929	0.00709	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00092	0.00702	CcSEcCtD
Flunitrazepam—Agitation—Paclitaxel—ovarian cancer	0.000911	0.00695	CcSEcCtD
Flunitrazepam—Angioedema—Paclitaxel—ovarian cancer	0.000906	0.00691	CcSEcCtD
Flunitrazepam—Malaise—Paclitaxel—ovarian cancer	0.000894	0.00682	CcSEcCtD
Flunitrazepam—Rash—Topotecan—ovarian cancer	0.000887	0.00676	CcSEcCtD
Flunitrazepam—Dermatitis—Topotecan—ovarian cancer	0.000886	0.00676	CcSEcCtD
Flunitrazepam—Ataxia—Epirubicin—ovarian cancer	0.000885	0.00675	CcSEcCtD
Flunitrazepam—Headache—Topotecan—ovarian cancer	0.000881	0.00672	CcSEcCtD
Flunitrazepam—Diplopia—Doxorubicin—ovarian cancer	0.000871	0.00664	CcSEcCtD
Flunitrazepam—Rash—Melphalan—ovarian cancer	0.000868	0.00662	CcSEcCtD
Flunitrazepam—Dermatitis—Melphalan—ovarian cancer	0.000867	0.00662	CcSEcCtD
Flunitrazepam—Asthenia—Vinorelbine—ovarian cancer	0.000863	0.00658	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00086	0.00656	CcSEcCtD
Flunitrazepam—Anxiety—Paclitaxel—ovarian cancer	0.000841	0.00642	CcSEcCtD
Flunitrazepam—Discomfort—Paclitaxel—ovarian cancer	0.000834	0.00636	CcSEcCtD
Flunitrazepam—CYP2C19—vagina—ovarian cancer	0.000832	0.0205	CbGeAlD
Flunitrazepam—Muscular weakness—Epirubicin—ovarian cancer	0.00083	0.00633	CcSEcCtD
Flunitrazepam—Dry mouth—Paclitaxel—ovarian cancer	0.000826	0.0063	CcSEcCtD
Flunitrazepam—Ataxia—Doxorubicin—ovarian cancer	0.000819	0.00625	CcSEcCtD
Flunitrazepam—Confusional state—Paclitaxel—ovarian cancer	0.000816	0.00622	CcSEcCtD
Flunitrazepam—CYP2B6—gonad—ovarian cancer	0.000807	0.0199	CbGeAlD
Flunitrazepam—Dizziness—Vinorelbine—ovarian cancer	0.000796	0.00607	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000795	0.00607	CcSEcCtD
Flunitrazepam—Tachycardia—Paclitaxel—ovarian cancer	0.00079	0.00602	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000782	0.00597	CcSEcCtD
Flunitrazepam—Muscular weakness—Doxorubicin—ovarian cancer	0.000768	0.00586	CcSEcCtD
Flunitrazepam—Rash—Vinorelbine—ovarian cancer	0.000759	0.00579	CcSEcCtD
Flunitrazepam—Dermatitis—Vinorelbine—ovarian cancer	0.000758	0.00578	CcSEcCtD
Flunitrazepam—Hypotension—Paclitaxel—ovarian cancer	0.000756	0.00577	CcSEcCtD
Flunitrazepam—Headache—Vinorelbine—ovarian cancer	0.000754	0.00575	CcSEcCtD
Flunitrazepam—GABRA2—lymph node—ovarian cancer	0.00074	0.0182	CbGeAlD
Flunitrazepam—Drowsiness—Epirubicin—ovarian cancer	0.000725	0.00553	CcSEcCtD
Flunitrazepam—CYP2B6—female reproductive system—ovarian cancer	0.000721	0.0177	CbGeAlD
Flunitrazepam—Somnolence—Paclitaxel—ovarian cancer	0.000719	0.00549	CcSEcCtD
Flunitrazepam—CYP2C9—female reproductive system—ovarian cancer	0.000714	0.0176	CbGeAlD
Flunitrazepam—Dry mouth—Docetaxel—ovarian cancer	0.0007	0.00534	CcSEcCtD
Flunitrazepam—Fatigue—Paclitaxel—ovarian cancer	0.000698	0.00532	CcSEcCtD
Flunitrazepam—Sweating—Epirubicin—ovarian cancer	0.000695	0.0053	CcSEcCtD
Flunitrazepam—Confusional state—Docetaxel—ovarian cancer	0.000692	0.00528	CcSEcCtD
Flunitrazepam—TSPO—lymph node—ovarian cancer	0.000685	0.0169	CbGeAlD
Flunitrazepam—CYP2E1—female reproductive system—ovarian cancer	0.000676	0.0167	CbGeAlD
Flunitrazepam—Drowsiness—Doxorubicin—ovarian cancer	0.000671	0.00512	CcSEcCtD
Flunitrazepam—Tachycardia—Docetaxel—ovarian cancer	0.000669	0.00511	CcSEcCtD
Flunitrazepam—Feeling abnormal—Paclitaxel—ovarian cancer	0.000667	0.00509	CcSEcCtD
Flunitrazepam—CYP2B6—vagina—ovarian cancer	0.000652	0.0161	CbGeAlD
Flunitrazepam—Sweating—Doxorubicin—ovarian cancer	0.000643	0.00491	CcSEcCtD
Flunitrazepam—Hypotension—Docetaxel—ovarian cancer	0.000641	0.00489	CcSEcCtD
Flunitrazepam—Somnolence—Docetaxel—ovarian cancer	0.00061	0.00465	CcSEcCtD
Flunitrazepam—Fatigue—Docetaxel—ovarian cancer	0.000591	0.00451	CcSEcCtD
Flunitrazepam—CYP2B6—testis—ovarian cancer	0.000582	0.0143	CbGeAlD
Flunitrazepam—Asthenia—Paclitaxel—ovarian cancer	0.000581	0.00443	CcSEcCtD
Flunitrazepam—Feeling abnormal—Docetaxel—ovarian cancer	0.000565	0.00431	CcSEcCtD
Flunitrazepam—CYP2E1—testis—ovarian cancer	0.000546	0.0134	CbGeAlD
Flunitrazepam—CYP3A4—female reproductive system—ovarian cancer	0.000544	0.0134	CbGeAlD
Flunitrazepam—Dizziness—Paclitaxel—ovarian cancer	0.000535	0.00408	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Epirubicin—ovarian cancer	0.000526	0.00401	CcSEcCtD
Flunitrazepam—Agitation—Epirubicin—ovarian cancer	0.000521	0.00397	CcSEcCtD
Flunitrazepam—Malaise—Epirubicin—ovarian cancer	0.000511	0.0039	CcSEcCtD
Flunitrazepam—Rash—Paclitaxel—ovarian cancer	0.00051	0.00389	CcSEcCtD
Flunitrazepam—Dermatitis—Paclitaxel—ovarian cancer	0.00051	0.00389	CcSEcCtD
Flunitrazepam—Headache—Paclitaxel—ovarian cancer	0.000507	0.00387	CcSEcCtD
Flunitrazepam—Asthenia—Docetaxel—ovarian cancer	0.000492	0.00375	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000487	0.00371	CcSEcCtD
Flunitrazepam—Agitation—Doxorubicin—ovarian cancer	0.000482	0.00368	CcSEcCtD
Flunitrazepam—Anxiety—Epirubicin—ovarian cancer	0.000481	0.00367	CcSEcCtD
Flunitrazepam—Discomfort—Epirubicin—ovarian cancer	0.000477	0.00364	CcSEcCtD
Flunitrazepam—Malaise—Doxorubicin—ovarian cancer	0.000473	0.00361	CcSEcCtD
Flunitrazepam—Dry mouth—Epirubicin—ovarian cancer	0.000472	0.0036	CcSEcCtD
Flunitrazepam—Confusional state—Epirubicin—ovarian cancer	0.000466	0.00356	CcSEcCtD
Flunitrazepam—Dizziness—Docetaxel—ovarian cancer	0.000454	0.00346	CcSEcCtD
Flunitrazepam—Tachycardia—Epirubicin—ovarian cancer	0.000452	0.00344	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Epirubicin—ovarian cancer	0.000447	0.00341	CcSEcCtD
Flunitrazepam—Anxiety—Doxorubicin—ovarian cancer	0.000445	0.00339	CcSEcCtD
Flunitrazepam—Discomfort—Doxorubicin—ovarian cancer	0.000441	0.00337	CcSEcCtD
Flunitrazepam—Dry mouth—Doxorubicin—ovarian cancer	0.000437	0.00333	CcSEcCtD
Flunitrazepam—Rash—Docetaxel—ovarian cancer	0.000432	0.0033	CcSEcCtD
Flunitrazepam—Hypotension—Epirubicin—ovarian cancer	0.000432	0.0033	CcSEcCtD
Flunitrazepam—Dermatitis—Docetaxel—ovarian cancer	0.000432	0.0033	CcSEcCtD
Flunitrazepam—Confusional state—Doxorubicin—ovarian cancer	0.000432	0.00329	CcSEcCtD
Flunitrazepam—Headache—Docetaxel—ovarian cancer	0.00043	0.00328	CcSEcCtD
Flunitrazepam—Tachycardia—Doxorubicin—ovarian cancer	0.000418	0.00319	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000414	0.00316	CcSEcCtD
Flunitrazepam—Somnolence—Epirubicin—ovarian cancer	0.000411	0.00314	CcSEcCtD
Flunitrazepam—Hypotension—Doxorubicin—ovarian cancer	0.0004	0.00305	CcSEcCtD
Flunitrazepam—Fatigue—Epirubicin—ovarian cancer	0.000399	0.00304	CcSEcCtD
Flunitrazepam—Feeling abnormal—Epirubicin—ovarian cancer	0.000381	0.00291	CcSEcCtD
Flunitrazepam—Somnolence—Doxorubicin—ovarian cancer	0.000381	0.0029	CcSEcCtD
Flunitrazepam—Fatigue—Doxorubicin—ovarian cancer	0.000369	0.00282	CcSEcCtD
Flunitrazepam—Feeling abnormal—Doxorubicin—ovarian cancer	0.000353	0.00269	CcSEcCtD
Flunitrazepam—Asthenia—Epirubicin—ovarian cancer	0.000332	0.00253	CcSEcCtD
Flunitrazepam—Asthenia—Doxorubicin—ovarian cancer	0.000307	0.00234	CcSEcCtD
Flunitrazepam—Dizziness—Epirubicin—ovarian cancer	0.000306	0.00233	CcSEcCtD
Flunitrazepam—Rash—Epirubicin—ovarian cancer	0.000292	0.00223	CcSEcCtD
Flunitrazepam—Dermatitis—Epirubicin—ovarian cancer	0.000291	0.00222	CcSEcCtD
Flunitrazepam—Headache—Epirubicin—ovarian cancer	0.00029	0.00221	CcSEcCtD
Flunitrazepam—Dizziness—Doxorubicin—ovarian cancer	0.000283	0.00216	CcSEcCtD
Flunitrazepam—Rash—Doxorubicin—ovarian cancer	0.00027	0.00206	CcSEcCtD
Flunitrazepam—Dermatitis—Doxorubicin—ovarian cancer	0.00027	0.00206	CcSEcCtD
Flunitrazepam—Headache—Doxorubicin—ovarian cancer	0.000268	0.00205	CcSEcCtD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000102	0.000947	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000101	0.000935	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	9.98e-05	0.000926	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	9.9e-05	0.000919	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	9.79e-05	0.000909	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	9.77e-05	0.000906	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PPP1CC—ovarian cancer	9.76e-05	0.000906	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—BRIP1—ovarian cancer	9.76e-05	0.000906	CbGpPWpGaD
Flunitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.55e-05	0.000887	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	9.55e-05	0.000887	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	9.55e-05	0.000887	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	9.55e-05	0.000887	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.5e-05	0.000882	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—YAP1—ovarian cancer	9.48e-05	0.00088	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	9.39e-05	0.000872	CbGpPWpGaD
Flunitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.38e-05	0.000871	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.33e-05	0.000866	CbGpPWpGaD
Flunitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.22e-05	0.000856	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.17e-05	0.000851	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	9.02e-05	0.000838	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	8.95e-05	0.000831	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	8.79e-05	0.000816	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	8.63e-05	0.000802	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYTB—ovarian cancer	8.61e-05	0.000799	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.19e-05	0.00076	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NME2—ovarian cancer	8.14e-05	0.000756	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.08e-05	0.00075	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—YAP1—ovarian cancer	8.06e-05	0.000748	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	8.03e-05	0.000746	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	8.03e-05	0.000745	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	7.92e-05	0.000735	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	7.86e-05	0.00073	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.82e-05	0.000726	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—MAPK1—ovarian cancer	7.81e-05	0.000725	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—FASN—ovarian cancer	7.72e-05	0.000717	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—MAPK1—ovarian cancer	7.72e-05	0.000716	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	7.67e-05	0.000712	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—SLC5A5—ovarian cancer	7.6e-05	0.000705	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—BRIP1—ovarian cancer	7.52e-05	0.000698	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PPP1CC—ovarian cancer	7.52e-05	0.000698	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NME2—ovarian cancer	7.43e-05	0.000689	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.36e-05	0.000683	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—SLC2A1—ovarian cancer	7.34e-05	0.000681	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.18e-05	0.000667	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.05e-05	0.000655	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CYP1B1—ovarian cancer	7.04e-05	0.000653	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYTB—ovarian cancer	6.95e-05	0.000645	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.93e-05	0.000643	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.91e-05	0.000641	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	6.9e-05	0.000641	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—MAPK1—ovarian cancer	6.86e-05	0.000636	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYTB—ovarian cancer	6.8e-05	0.000631	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—MAPK1—ovarian cancer	6.73e-05	0.000625	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—MAPK1—ovarian cancer	6.62e-05	0.000614	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—FASN—ovarian cancer	6.57e-05	0.00061	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—YAP1—ovarian cancer	6.55e-05	0.000608	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—SLC5A5—ovarian cancer	6.46e-05	0.0006	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NME2—ovarian cancer	6.35e-05	0.000589	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.3e-05	0.000585	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—HRAS—ovarian cancer	6.27e-05	0.000582	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—SLC2A1—ovarian cancer	6.24e-05	0.000579	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PPP2R1A—ovarian cancer	6.24e-05	0.000579	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—HRAS—ovarian cancer	6.19e-05	0.000575	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—BRIP1—ovarian cancer	6.07e-05	0.000564	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PPP1CC—ovarian cancer	6.07e-05	0.000564	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP1B1—ovarian cancer	5.98e-05	0.000555	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PPP1CC—ovarian cancer	5.95e-05	0.000552	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—BRIP1—ovarian cancer	5.95e-05	0.000552	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	5.91e-05	0.000549	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—ABCB1—ovarian cancer	5.79e-05	0.000538	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—TYMS—ovarian cancer	5.69e-05	0.000528	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—MAPK1—ovarian cancer	5.64e-05	0.000524	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.63e-05	0.000523	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—HRAS—ovarian cancer	5.5e-05	0.000511	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—HRAS—ovarian cancer	5.4e-05	0.000502	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.38e-05	0.0005	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—FASN—ovarian cancer	5.34e-05	0.000495	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—HRAS—ovarian cancer	5.31e-05	0.000493	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PPP2R1A—ovarian cancer	5.31e-05	0.000492	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—SLC5A5—ovarian cancer	5.25e-05	0.000487	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYTB—ovarian cancer	5.25e-05	0.000487	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.14e-05	0.000477	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.13e-05	0.000476	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—SLC2A1—ovarian cancer	5.07e-05	0.000471	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—YAP1—ovarian cancer	5.05e-05	0.000468	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ABCB1—ovarian cancer	4.93e-05	0.000457	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NME2—ovarian cancer	4.9e-05	0.000455	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP1B1—ovarian cancer	4.86e-05	0.000451	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—TYMS—ovarian cancer	4.84e-05	0.000449	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYTB—ovarian cancer	4.79e-05	0.000444	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.68e-05	0.000434	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PPP1CC—ovarian cancer	4.59e-05	0.000426	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—BRIP1—ovarian cancer	4.59e-05	0.000426	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CAV1—ovarian cancer	4.58e-05	0.000426	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—HRAS—ovarian cancer	4.53e-05	0.00042	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.39e-05	0.000407	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PPP2R1A—ovarian cancer	4.31e-05	0.0004	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—BRIP1—ovarian cancer	4.18e-05	0.000388	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PPP1CC—ovarian cancer	4.18e-05	0.000388	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CG—ovarian cancer	4.18e-05	0.000388	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—FASN—ovarian cancer	4.11e-05	0.000382	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYTB—ovarian cancer	4.09e-05	0.00038	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—YAP1—ovarian cancer	4.07e-05	0.000378	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—SLC5A5—ovarian cancer	4.05e-05	0.000376	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ABCB1—ovarian cancer	4e-05	0.000372	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4e-05	0.000371	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—YAP1—ovarian cancer	3.99e-05	0.00037	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—TYMS—ovarian cancer	3.93e-05	0.000365	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—SLC2A1—ovarian cancer	3.91e-05	0.000363	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CAV1—ovarian cancer	3.9e-05	0.000362	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP1B1—ovarian cancer	3.75e-05	0.000348	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CD—ovarian cancer	3.67e-05	0.000341	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PPP1CC—ovarian cancer	3.57e-05	0.000332	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—BRIP1—ovarian cancer	3.57e-05	0.000332	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CG—ovarian cancer	3.55e-05	0.00033	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.34e-05	0.00031	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	3.32e-05	0.000308	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—FASN—ovarian cancer	3.32e-05	0.000308	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—SLC5A5—ovarian cancer	3.27e-05	0.000303	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—FASN—ovarian cancer	3.25e-05	0.000302	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CB—ovarian cancer	3.2e-05	0.000297	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—SLC5A5—ovarian cancer	3.2e-05	0.000297	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CAV1—ovarian cancer	3.17e-05	0.000294	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYTB—ovarian cancer	3.16e-05	0.000293	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—SLC2A1—ovarian cancer	3.15e-05	0.000293	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CD—ovarian cancer	3.12e-05	0.00029	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—SLC2A1—ovarian cancer	3.09e-05	0.000287	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ABCB1—ovarian cancer	3.09e-05	0.000286	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—YAP1—ovarian cancer	3.08e-05	0.000286	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.05e-05	0.000283	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.05e-05	0.000283	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—TYMS—ovarian cancer	3.03e-05	0.000281	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP1B1—ovarian cancer	3.02e-05	0.000281	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP1B1—ovarian cancer	2.96e-05	0.000275	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CG—ovarian cancer	2.89e-05	0.000268	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—YAP1—ovarian cancer	2.81e-05	0.00026	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.78e-05	0.000258	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTEN—ovarian cancer	2.77e-05	0.000257	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.76e-05	0.000256	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.76e-05	0.000256	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CB—ovarian cancer	2.72e-05	0.000253	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	2.68e-05	0.000249	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.68e-05	0.000248	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	2.63e-05	0.000244	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.6e-05	0.000242	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CD—ovarian cancer	2.54e-05	0.000235	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—FASN—ovarian cancer	2.51e-05	0.000233	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ABCB1—ovarian cancer	2.49e-05	0.000231	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SLC5A5—ovarian cancer	2.47e-05	0.000229	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—TYMS—ovarian cancer	2.45e-05	0.000227	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CAV1—ovarian cancer	2.44e-05	0.000227	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.44e-05	0.000227	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ABCB1—ovarian cancer	2.44e-05	0.000226	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—YAP1—ovarian cancer	2.4e-05	0.000223	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—TYMS—ovarian cancer	2.39e-05	0.000222	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SLC2A1—ovarian cancer	2.38e-05	0.000221	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.37e-05	0.00022	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTEN—ovarian cancer	2.35e-05	0.000218	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.33e-05	0.000217	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—FASN—ovarian cancer	2.29e-05	0.000212	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP1B1—ovarian cancer	2.28e-05	0.000212	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SLC5A5—ovarian cancer	2.25e-05	0.000209	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CG—ovarian cancer	2.22e-05	0.000206	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CB—ovarian cancer	2.21e-05	0.000205	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SLC2A1—ovarian cancer	2.17e-05	0.000202	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.13e-05	0.000197	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.09e-05	0.000194	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP1B1—ovarian cancer	2.08e-05	0.000193	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	2.03e-05	0.000188	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.02e-05	0.000187	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CAV1—ovarian cancer	1.97e-05	0.000183	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CD—ovarian cancer	1.96e-05	0.000182	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—FASN—ovarian cancer	1.95e-05	0.000181	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CA—ovarian cancer	1.95e-05	0.000181	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CAV1—ovarian cancer	1.93e-05	0.000179	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SLC5A5—ovarian cancer	1.92e-05	0.000178	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTEN—ovarian cancer	1.91e-05	0.000177	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.88e-05	0.000175	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.86e-05	0.000172	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—YAP1—ovarian cancer	1.85e-05	0.000172	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—TYMS—ovarian cancer	1.85e-05	0.000172	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.85e-05	0.000171	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.84e-05	0.000171	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.82e-05	0.000169	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CG—ovarian cancer	1.79e-05	0.000167	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1.78e-05	0.000165	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CG—ovarian cancer	1.76e-05	0.000163	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.72e-05	0.000159	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CB—ovarian cancer	1.7e-05	0.000158	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—TYMS—ovarian cancer	1.68e-05	0.000156	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CA—ovarian cancer	1.66e-05	0.000154	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—AKT1—ovarian cancer	1.59e-05	0.000148	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.58e-05	0.000147	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CD—ovarian cancer	1.58e-05	0.000146	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.57e-05	0.000146	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CD—ovarian cancer	1.55e-05	0.000143	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—FASN—ovarian cancer	1.51e-05	0.00014	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CAV1—ovarian cancer	1.49e-05	0.000138	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.48e-05	0.000138	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTEN—ovarian cancer	1.47e-05	0.000137	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.47e-05	0.000136	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—TYMS—ovarian cancer	1.44e-05	0.000134	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.43e-05	0.000133	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.42e-05	0.000132	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CB—ovarian cancer	1.38e-05	0.000128	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.37e-05	0.000128	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CAV1—ovarian cancer	1.36e-05	0.000126	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.36e-05	0.000126	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—AKT1—ovarian cancer	1.35e-05	0.000126	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CA—ovarian cancer	1.35e-05	0.000125	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CB—ovarian cancer	1.35e-05	0.000125	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.3e-05	0.00012	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.24e-05	0.000115	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.22e-05	0.000113	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.19e-05	0.000111	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTEN—ovarian cancer	1.19e-05	0.00011	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTEN—ovarian cancer	1.16e-05	0.000108	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CAV1—ovarian cancer	1.16e-05	0.000108	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.13e-05	0.000105	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—TYMS—ovarian cancer	1.11e-05	0.000103	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.11e-05	0.000103	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AKT1—ovarian cancer	1.1e-05	0.000102	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.09e-05	0.000101	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.06e-05	9.81e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.04e-05	9.65e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CA—ovarian cancer	1.04e-05	9.64e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CB—ovarian cancer	9.48e-06	8.8e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CD—ovarian cancer	9.29e-06	8.62e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTEN—ovarian cancer	8.98e-06	8.34e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CAV1—ovarian cancer	8.95e-06	8.31e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AKT1—ovarian cancer	8.49e-06	7.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CA—ovarian cancer	8.38e-06	7.78e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CA—ovarian cancer	8.21e-06	7.62e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTEN—ovarian cancer	8.19e-06	7.6e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CG—ovarian cancer	8.16e-06	7.57e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CB—ovarian cancer	8.1e-06	7.52e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CD—ovarian cancer	7.17e-06	6.65e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTEN—ovarian cancer	7e-06	6.49e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AKT1—ovarian cancer	6.85e-06	6.36e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AKT1—ovarian cancer	6.71e-06	6.23e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CA—ovarian cancer	6.33e-06	5.88e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CB—ovarian cancer	6.25e-06	5.8e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CA—ovarian cancer	5.78e-06	5.36e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTEN—ovarian cancer	5.4e-06	5.01e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AKT1—ovarian cancer	5.17e-06	4.8e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CA—ovarian cancer	4.94e-06	4.58e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AKT1—ovarian cancer	4.72e-06	4.38e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKT1—ovarian cancer	4.03e-06	3.74e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.81e-06	3.54e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKT1—ovarian cancer	3.11e-06	2.89e-05	CbGpPWpGaD
